SnapMD Revenue and Competitors

Location

$16.3M

Total Funding

Estimated Revenue & Valuation

  • SnapMD's estimated annual revenue is currently $42k per year.(i)
  • SnapMD's estimated revenue per employee is $14,000
  • SnapMD's total funding is $16.3M.

Employee Data

  • SnapMD has 3 Employees.(i)
  • SnapMD grew their employee count by -50% last year.

SnapMD's People

NameTitleEmail/Phone
1
Client Success Specialist, Client Success TeamReveal Email/Phone
2
Financial ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$77M0N/A$866MN/A
#2
$8.6M66N/AN/AN/A
#3
$49.9M1688%N/AN/A
#4
$5.7M0N/A$8MN/A
#5
$274M1398N/AN/AN/A
#6
$7.7M61N/AN/AN/A
#7
$5.4M0N/A$1.2MN/A
#8
$123.2M365N/AN/AN/A
#9
$4.3M23N/AN/AN/A
#10
$1M12N/AN/AN/A
#11
$76.9M259N/AN/AN/A
#12
$42.1M1456%$32.5MN/A
#13
$0.5M3N/AN/AN/A
#14
$3.9M3716%$14.6MN/A
#15
$15.1M104N/AN/AN/A
#16
$27.5M102N/AN/AN/A
#17
$205.6M50643%N/AN/A
#18
$2.6M26N/AN/AN/A
#19
$123.6M695-1%$88.7MN/A
#20
$19670M176108N/AN/A$30.3B
Add Company

What Is SnapMD?

SnapMD is the full-service Virtual Care Management (VCM) telehealth enterprise-software leader, enabling healthcare providers to engage their patients via a comprehensive, secure, HIPAA-compliant, cloud-based telemedicine platform with powerful back-end systems to manage the digital health care continuum. SnapMD offers the software and services that healthcare providers need to improve access to convenient and effective care. SnapMDâ??s robust, scalable, private-label VCM platform is designed to handle multiple service-lines, and can be deployed as a single telehealth platform across the enterprise. \n\nThe SnapMD private-label VCM telemedicine platform allows providers to extend their reach of care by leveraging secure live video consultations between ambulatory patients and their primary care and specialty care physicians. As a cloud-based communications platform, our SaaS solution was developed to enable healthcare providers to directly engage patients remotely in a â??virtual careâ?? environment, using readily available consumer based devices.\n \nBy deploying telehealth services with SnapMDâ??s VCM platform, healthcare providers can conduct scheduled virtual consultations for patients receiving ongoing treatment and conduct on-demand consultations to: help reduce avoidable visits in urgent-care or emergency room settings, provide remote medical services such as in-school virtual clinics, and collaborate physician-to-physician. With our VCM technology, healthcare providers have another powerful tool to help them extend their brand, reach-of-care and find efficiencies in personnel utilization while continuing to deliver high quality healthcare services.

keywords:saas

$16.3M

Total Funding

3

Number of Employees

$42k

Revenue (est)

-50%

Employee Growth %

N/A

Valuation

N/A

Accelerator

SnapMD News

2022-04-20 - Global Telemedicine Market to See Major Growth by 2028 ...

... GlobalMed, Honeywell HomMed, InTouch Technologies, Inc., McKesson Corporation, MDLIVE Inc., MeMD, SnapMD, Inc., Teladoc Health, Inc., Telemedicine, Inc.

2022-04-17 - Telemedicine Market 2021 Stats, Trends, Size & Ecosystem ...

... Honeywell HomMed, InTouch Technologies, Inc., McKesson Corporation, MDLIVE Inc., MeMD, SnapMD, Inc., Teladoc Health, Inc., Telemedicine,...

2022-04-06 - Telemedicine Market to Gather USD 78960 Million by last few ...

... Philips Healthcare; Cloudvisit Telemedicine; Maestros Telemedicine; Medisoft Telemedicine; Reach Health; SnapMD Telemedicine Technology.

2018-09-19 - LA-Based Telehealth Company SnapMD Raises $7.1 Million To Grow Its Platform

Founded by Dave Skibinski, SnapMD is a Los Angeles-based enterprise telehealth company that has raised $7.1 million in Series B funding. The investors in this round were undisclosed. But the company said that the participating investors in this round were returning from its original round.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M3N/AN/A
#2
$0.4M3-25%N/A
#3
$0.2M3-25%N/A
#4
$0.2M30%N/A
#5
$0.3M40%N/A